Shoulder Innovations, a medical technology company, reported $17.2 million in second-quarter net revenue, up 56% from $11 million during the same period in 2025.
The medical technology company reported a $10.2 million net loss for the quarter, compared with a $19.2 million net loss a year earlier, according to an Aug. 6 news release.
Shoulder Innovations raised its full-year 2026 net revenue guidance to $67 million to $69 million, representing approximately 42% to 46% growth over 2025. Its previous guidance was $65 million to $68 million.
The company sold 2,238 implant systems during the quarter, an approximate 50% increase from the same period in 2025, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
